Brown Brothers Harriman & Co’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,500	Closed	-$17K	–	1352
2019 Q3	$17K	Hold	3,500	–	–	﹤0.01%	827
2019 Q2	$21K	Hold	3,500	–	–	﹤0.01%	739
2019 Q1	$20K	Sell	3,500 -1,000	-22%	-$10.3K	﹤0.01%	734
2018 Q4	$61K	Hold	4,500	–	–	﹤0.01%	498
2018 Q3	$87K	Hold	4,500	–	–	﹤0.01%	472
2018 Q2	$115K	Hold	4,500	–	–	﹤0.01%	403
2018 Q1	$91K	Hold	4,500	–	–	﹤0.01%	427
2017 Q4	$90K	Hold	4,500	–	–	﹤0.01%	446
2017 Q3	$93K	Hold	4,500	–	–	﹤0.01%	416
2017 Q2	$67K	Hold	4,500	–	–	﹤0.01%	456
2017 Q1	$72K	Hold	4,500	–	–	﹤0.01%	455
2016 Q4	$57K	Hold	4,500	–	–	﹤0.01%	469
2016 Q3	$126K	Hold	4,500	–	–	﹤0.01%	358
2016 Q2	$158K	Hold	4,500	–	–	﹤0.01%	327
2016 Q1	$123K	Hold	4,500	–	–	﹤0.01%	356
2015 Q4	$154K	Hold	4,500	–	–	﹤0.01%	348
2015 Q3	$129K	Buy	4,500 +3,500	+350%	+$150K	﹤0.01%	365
2015 Q2	$45K	Hold	1,000	–	–	﹤0.01%	512
2015 Q1	$35K	Hold	1,000	–	–	﹤0.01%	539
2014 Q4	$27K	Buy	+1,000	New	+$24.3K	﹤0.01%	596

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Brothers Harriman & Co's DPLO Position: Q4 2019 in Review

Brown Brothers Harriman & Co sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 3,500 shares — an estimated $17K sold.

Brown Brothers Harriman & Co first reported a position in DPLO in Q4 2014 and held it in 20 quarters. The position peaked at $158K in Q2 2016. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

Brown Brothers Harriman & Co reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
Brown Brothers Harriman & Co sold 3,500 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $17K.
Brown Brothers Harriman & Co first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 20 quarters.
Brown Brothers Harriman & Co's DIPLOMAT PHARMACY, INC. position peaked at $158K in Q2 2016.
138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2019, filed 14 Feb 2020.